Enlivex (ENLV) Dividends Paid - Common (2013 - 2016)
Enlivex (ENLV) posted quarterly Dividends Paid - Common of -$2.8 million for Q3 2016, up 33.15% year-over-year from -$2.1 million in Q4 2015, and down 132.03% quarter-over-quarter from $8.7 million in Q2 2016.
Enlivex (ENLV) Dividends Paid - Common (2013 - 2016) Analysis & Trends
Enlivex's Dividends Paid - Common history runs 4 years deep, the most recent figure standing at -$2.8 million for Q3 2016.
- In Q3 2016, Dividends Paid - Common rose 33.15% year-over-year to -$2.8 million; the TTM figure through Sep 2016 stood at $22.7 million (up 46.39% YoY), while the FY2015 annual figure was $7.3 million, down 31.15% from the prior year.
- Dividends Paid - Common for Q3 2016 stood at -$2.8 million, down from $8.7 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $34.1 million in Q3 2014, with the low at -$4.2 million in Q3 2015.
- The 4-year median for Dividends Paid - Common is $3.5 million (2014), against an average of $5.6 million.
- Peak annual rise in Dividends Paid - Common reached 3987.19% in 2014, while the deepest fall reached 4288.24% in 2014.
- Enlivex's Dividends Paid - Common stood at $270000.0 in 2013, then soared by 3819.63% to $10.6 million in 2014, then sank by 31.15% to $7.3 million in 2015, then tumbled by 138.31% to -$2.8 million in 2016.
- Business Quant data shows ENLV's Dividends Paid - Common at -$2.8 million in Q3 2016, $8.7 million in Q2 2016, and $9.5 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -2.79 Mn |
| Sep 30, 2016 | -2.79 Mn |
| Jun 30, 2016 | 8.71 Mn |
| Jun 30, 2016 | 8.71 Mn |
| Mar 31, 2016 | 9.53 Mn |
| Mar 31, 2016 | 9.53 Mn |
| Dec 31, 2015 | 7.29 Mn |
| Dec 31, 2015 | 7.29 Mn |
| Sep 30, 2015 | -4.18 Mn |
| Sep 30, 2015 | -4.18 Mn |
| Jun 30, 2015 | 2.11 Mn |
| Jun 30, 2015 | 2.11 Mn |
| Mar 31, 2015 | 7.01 Mn |
| Mar 31, 2015 | 7.01 Mn |
| Dec 31, 2014 | 10.58 Mn |
| Dec 31, 2014 | 10.58 Mn |
| Sep 30, 2014 | 34.13 Mn |
| Sep 30, 2014 | 34.13 Mn |
| Jun 30, 2014 | -712,000.00 |
| Jun 30, 2014 | -712,000.00 |